Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Los términos de búsqueda han de ser en inglés.

Synthesis of secondary metabolites in filamentous fungi

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TODE20200723001
Publicado:
30/07/2020
Caducidad:
31/07/2021
Resumen:
A Berlin-based university has developed a process of synthesis of secondary metabolites in fungal host organisms for the production of novel antibiotics. The institute is interested in a cooperation in the framework of a license or a research cooperation agreement.

Details

Tittle:
Synthesis of secondary metabolites in filamentous fungi
Summary:
A Berlin-based university has developed a process of synthesis of secondary metabolites in fungal host organisms for the production of novel antibiotics. The institute is interested in a cooperation in the framework of a license or a research cooperation agreement.
Description:
Fungal secondary metabolites have a long history as antibiotic agents. One prominent example is penicillin. Novel antibiotics are often based on cyclic depsipeptides (CDPs). However, the production of these antibiotics on an industrial scale is known to be problematic.

A Berlin-based university has developed a solution for this problem. Optimization of the synthesis can be achieved by using fungal expression systems. Expression systems are genetic constructs (a gene encoded by DNA) that are designed to produce a protein, or an RNA (ribonucleic acid), either inside or outside a cell. Expression systems can be used in the commercial production of enzymes or therapeutics.

The innovation presented here contains a process for the synthesis of secondary metabolites such as cyclodepsipeptides in fungal host organisms (genera: Aspergillus, Penicillum, yeast). The necessary fungal enzymes can be modified by the introduction of altered gene sequences (synthetic or designed by polymerase chain reaction (PCR)).

Expression is performed by an inducible, controllable and metabolism-independent system, such as the tetracycline (Tet) system. This system can be switched on or off by constitutive, inducible or suppressible promoters and thus offers the possibility for further optimization. Following fed-batch cultivation, the extraction of the secondary metabolite from the biomass achieves satisfactory yields with high purity and low background contamination by other metabolites.

The university is interested in a cooperation in the framework of a license agreement or a research cooperation agreement. A future licensee would have the authorization to use the technology in return for a fee or a share of royalties. The client would also agree to a research cooperation agreement that aims at the joint further development of the technology.
Advantages and Innovations:
- The process is able to guarantee a high yield and purity
- Controllable cultivation inside bio reactors is possible
- Fungi or its enzymes can be modified
Stage of Development:
Under development/lab tested
IPs:
Patent(s) applied for but not yet granted,Patents granted
CommeR Statunts Regarding IPR Status:
Patent applications are pending for Israel, the United States, China and Canada.

For the following countries patent applications have been approved: Denmark, Finland, France, Germany, Switzerland, United Kingdom, Spain, Austria, Sweden, Japan and the Netherlands

Partner sought

Type and Role of Partner Sought:
The university is looking for partners from the biotechnology or pharma industry or biological research for a license or a research cooperation agreement.

In the framework of a license agreement partners like industry, SMEs or academic would be authorized to use the licensed technology, e.g. for the production of novel antibiotics.
In a research cooperation agreement the partner could be industry, a SME or a university to further develop the technology together.

Client

Type and Size of Client:
University
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
German

Keywords

Technology Keywords:
06006012 Bioprocesos
06002004 Ingeniería de proteínas